Silence Therapeutics plc — Form D

Silence Therapeutics plc of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2010-01-05. The offering totals $8.5M. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Annette ClancyDirectorLondon, X0
Melvyn Curnock DaviesDirectorLondon, X0
Jerry Curnock RandallDirectorLondon, X0
Peter Curnock ReynoldsDirectorLondon, X0
David Curnock U'PrichardDirectorLondon, X0
Melvyn Curnock DaviesExecutive OfficerLondon, X0
Iain RossExecutive OfficerLondon, X0
James Ede-GolightlyDirectorLondon, X0
Alistair GrayDirectorLondon, X0
Craig ToomanExecutive OfficerLondon, X0
Dave LemusDirectorLondon, X0
Giles CampionExecutive OfficerLondon, X0
Romano StevenDirectorLondon, X0
Michael H DavidsonDirectorLondon, X0
Mark RotheraDirectorLondon, X0
Mark RotheraExecutive OfficerLondon, X0
Iain RossDirectorLondon, X0
Barbara RuskinExecutive OfficerLondon, X0
Jeremy Curnock CookDirectorMontreal, A8
Bernd Curnock WetzelDirectorLondon, X0

Other filings by this issuer (3)

FiledFormOfferingSold
2021-02-18D$45.5M$45.5M
2010-01-05D
2010-01-05D

More